← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicBayerSN-38, which is predominant…Phase 1

BAY 3547922 (BAY 3547922)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

BMD006 (BMD006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleBristol-Myers SquibbPhase 2

BMS-986148 (BMS-986148)

Advanced Cancer · Advanced Cancer

#AdvancedCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 2상태 DISCONTINUED
ADCBiologicstaleBioNTech SEPhase 2

BNT326 (BNT326)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab Mafodotin, Cyclophosphamide and Dexamethasone)

Relapsed/Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 3%임상시험 2상태 DISCONTINUED
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin frozen liquid)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 34%임상시험 2상태 ACTIVE
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin, Venetoclax)

Multiple Myeloma; Multiple Myeloma in Relapse · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleNational Cancer Institute (NCI)Phase 1

Brachyury-TRICOM (Brachyury-TRICOM)

Breast Cancer; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleLymphoma Study AssociationPhase 3

Carboplatine (Carboplatine)

Lymphoma, Large-Cell, Diffuse · Hodgkin Disease

#HodgkinDisease#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleDualityBio Inc.Phase 2

DB-1305/BNT325 (DB-1305/BNT325)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 2

DB-1310 (DB-1310)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Dan222 + Niraparib (Dan222 + Niraparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy)

Gastric Cancer · PD-1

#PD-1#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Bicalutamide)

Extramammary Paget Disease; Scrotum Disease · Extramammary Paget Disease

#ExtramammaryPagetDisease#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleRemeGenPhase 3

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Tislelizumab+Oxaliplatin+Capecitabine)

Gastric Carcinoma · Gastric Carcinoma

#GastricCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleThe First Affiliated Hospital w…Preclinical

Disitamb Vedotin (Disitamb Vedotin)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 ACTIVE
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleDavid OhPhase 2

Etrumadenant (Etrumadenant)

Prostate Adenocarcinoma; Prostate Cancer · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleBioAtla, Inc.Phase 2

BA3071 (Evalstotug, Evalstotug (BA3071))

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 ACTIVE

32 / 54 페이지

← 이전다음 →